Chris Gibson, Recursion’s head, cited the role small business grants played in helping Recursion grow its business.

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

We recently compiled a list of the Last Week’s Top 10 Stocks Post Double-Digit Gains. In this article, we are going to take a ...

CompanyOverview|NASDAQ:RXRX] Recursion Pharmaceuticals' (NASDAQ: RXRX) stock price has seen a dramatic increase, not due to ...

Recursion CEO Chris Gibson defends the NIH, investing $1 million into a pre-seed venture to encourage critical research and ...

If policymakers fail to act swiftly to restore medical research funding, then it’s up to those of us in the industry with the ...

That was the case for Recursion Pharmaceuticals, a now publicly traded company that applies artificial intelligence to drug discovery and development. With layoffs at the NIH underway and its ...

Altitude Lab Fund will provide pre-seed funding for early-stage startups affected by changes to grant programs administered ...

A Google software engineer's LinkedIn post admitting to a lack of fundamental coding skills—including SQL, Git, and even ...